HTLF Bank Invests $335,000 in Colgate-Palmolive (NYSE:CL)

HTLF Bank bought a new position in shares of Colgate-Palmolive (NYSE:CLFree Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The fund bought 4,200 shares of the company’s stock, valued at approximately $335,000.

Other hedge funds have also recently bought and sold shares of the company. OFI Invest Asset Management acquired a new stake in shares of Colgate-Palmolive in the third quarter valued at about $25,000. Avion Wealth grew its holdings in Colgate-Palmolive by 78.1% during the 4th quarter. Avion Wealth now owns 399 shares of the company’s stock valued at $32,000 after purchasing an additional 175 shares in the last quarter. McGlone Suttner Wealth Management Inc. acquired a new stake in shares of Colgate-Palmolive during the fourth quarter valued at about $34,000. Quarry LP lifted its stake in shares of Colgate-Palmolive by 48.2% in the second quarter. Quarry LP now owns 446 shares of the company’s stock worth $34,000 after acquiring an additional 145 shares in the last quarter. Finally, Kayne Anderson Rudnick Investment Management LLC boosted its holdings in Colgate-Palmolive by 142.0% in the third quarter. Kayne Anderson Rudnick Investment Management LLC now owns 496 shares of the company’s stock valued at $35,000 after purchasing an additional 291 shares during the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Insider Buying and Selling at Colgate-Palmolive

In related news, Director C Martin Harris sold 2,760 shares of the stock in a transaction that occurred on Wednesday, January 31st. The shares were sold at an average price of $84.50, for a total transaction of $233,220.00. Following the completion of the sale, the director now directly owns 19,272 shares of the company’s stock, valued at $1,628,484. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In other news, Director C Martin Harris sold 2,760 shares of the stock in a transaction on Wednesday, January 31st. The stock was sold at an average price of $84.50, for a total transaction of $233,220.00. Following the completion of the sale, the director now owns 19,272 shares in the company, valued at approximately $1,628,484. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Jennifer Daniels sold 61,633 shares of the company’s stock in a transaction on Thursday, February 1st. The shares were sold at an average price of $83.93, for a total value of $5,172,857.69. Following the sale, the insider now directly owns 57,948 shares of the company’s stock, valued at $4,863,575.64. The disclosure for this sale can be found here. In the last three months, insiders sold 232,371 shares of company stock valued at $19,505,099. 0.34% of the stock is owned by insiders.

Colgate-Palmolive Stock Up 1.1 %

Colgate-Palmolive stock opened at $87.13 on Friday. The company’s 50-day moving average price is $87.10 and its two-hundred day moving average price is $80.78. The stock has a market cap of $71.62 billion, a price-to-earnings ratio of 31.34, a PEG ratio of 3.26 and a beta of 0.42. Colgate-Palmolive has a 52 week low of $67.62 and a 52 week high of $90.37. The company has a current ratio of 1.11, a quick ratio of 0.71 and a debt-to-equity ratio of 8.59.

Colgate-Palmolive (NYSE:CLGet Free Report) last announced its earnings results on Friday, January 26th. The company reported $0.87 EPS for the quarter, topping the consensus estimate of $0.85 by $0.02. Colgate-Palmolive had a return on equity of 509.75% and a net margin of 11.82%. The firm had revenue of $4.95 billion for the quarter, compared to analysts’ expectations of $4.89 billion. During the same quarter in the previous year, the company earned $0.77 earnings per share. The firm’s quarterly revenue was up 6.9% compared to the same quarter last year. On average, analysts expect that Colgate-Palmolive will post 3.5 EPS for the current fiscal year.

Colgate-Palmolive Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Monday, April 22nd will be given a $0.50 dividend. The ex-dividend date of this dividend is Friday, April 19th. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.48. This represents a $2.00 annualized dividend and a yield of 2.30%. Colgate-Palmolive’s payout ratio is 69.06%.

Wall Street Analysts Forecast Growth

CL has been the subject of a number of research reports. Raymond James upgraded Colgate-Palmolive from a “market perform” rating to an “outperform” rating and set a $91.00 price target for the company in a research note on Monday, January 29th. Evercore ISI lifted their target price on Colgate-Palmolive from $90.00 to $96.00 and gave the stock an “outperform” rating in a research report on Monday, April 8th. UBS Group upped their price target on Colgate-Palmolive from $93.00 to $95.00 and gave the company a “buy” rating in a research report on Monday, January 29th. Stifel Nicolaus lifted their price objective on shares of Colgate-Palmolive from $89.00 to $94.00 and gave the stock a “buy” rating in a report on Wednesday, April 10th. Finally, Barclays increased their target price on shares of Colgate-Palmolive from $82.00 to $84.00 and gave the stock an “equal weight” rating in a report on Friday, April 12th. Three analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $89.50.

Check Out Our Latest Analysis on Colgate-Palmolive

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Articles

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.